ATG4B and Huntington disease: Moreover, we provide evidence that AZD8055 ameliorates HD progression in an Atg4b-dependent manner, demonstrating that inducers of Atg4b-dependent autophagic flux are putative candidates for a disease modifying therapy in HD.